...
首页> 外文期刊>Acta tropica: Journal of Biomedical Sciences >Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria
【24h】

Risk factors for Plasmodium falciparum and Plasmodium vivax gametocyte carriage in Papua New Guinean children with uncomplicated malaria

机译:巴布亚新几内亚患有单纯性疟疾的儿童恶性疟原虫和间日疟原虫配子体运输的危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There are limited data on gametocytaemia risk factors before/after treatment with artemisinin combination therapy in children from areas with transmission of multiple Plasmodium species. We utilised data from a randomised trial comparing artemether-lumefantrine (AL) and artemisinin-naphthoquine (AN) in 230 Papua New Guinean children aged 0.5-5 years with uncomplicated malaria in whom determinants of gametocytaemia by light microscopy were assessed at baseline using logistic regression and during follow-up using multilevel mixed effects modelling. Seventy-four (32%) and 18 (8%) children presented with P. falciparum and P. vivax gametocytaemia, respectively. Baseline P. falciparum gametocytaemia was associated with Hackett spleen grade 1 (odds ratio (95% CI) 4.01 (1.60-10.05) vs grade 0; P < 0.001) and haemoglobin (0.95 (0.92-0.97) per 1 g/L increase; P < 0.001), and P. falciparum asexual parasitaemia in slide-positive cases (0.36 (0.19-0.68) for a 10-fold increase; P = 0.002). Baseline P. vivax gametocytaemia was associated with Hackett grade 2 (12.66 (1.31-122.56); P = 0.028), mixed P. falciparum/vivax infection (0.16 (0.03-1.00); P = 0.050), P. vivax asexual parasitaemia (5.68 (0.98-33.04); P = 0.053) and haemoglobin (0.94 (0.88-1.00); P = 0.056). For post-treatment P. falciparum gametocytaemia, independent predictors were AN vs AL treatment (4.09 (1.43-11.65)), haemoglobin (0.95 (0.93-0.97)), presence/absence of P. falciparum asexual forms (3.40 (1.66-0.68)) and day post-treatment (0.086 (0.82-0.90)) (P < 0.001). Post-treatment P. vivax gametocytaemia was predicted by presence of P. vivax asexual forms (596 (12-28,433); P < 0.001). Consistent with slow P. falciparum gametocyte maturation, low haemoglobin, low asexual parasite density and higher spleen grading, markers of increased prior infection exposure/immunity, were strong associates of pre-treatment gametocyte positivity. The persistent inverse association between P. falciparum gametocytaemia and haemoglobin during follow-up suggests an important role for bone marrow modulation of gametocytogenesis. In P. vivax infections, baseline and post-treatment gametocyte carriage was positively related to the acute parasite burden, reflecting the close association between the development of asexual and sexual forms. (C)2016 Elsevier B.V. All rights reserved.
机译:对于来自多种疟原虫物种传播地区的儿童,在用青蒿素联合疗法治疗之前/之后,有关细胞凋亡的危险因素的数据有限。我们利用随机试验中的数据比较了蒿甲醚-荧光粉(AL)和青蒿素-萘醌(AN)在230名0.5-5岁的巴布亚新几内亚儿童中的并发疟疾情况,这些儿童通过光学显微镜在基线时使用logistic回归评估了配子菌血症的决定因素并在随访过程中使用多级混合效果建模。分别有74名(32%)和18名(8%)儿童出现恶性疟原虫和间日疟原虫配子体血症。基线恶性疟原虫的细胞凋亡与1级Hackett脾脏(奇数比(95%CI)4.01(1.60-10.05)vs 0级; P <0.001)和血红蛋白(0.95(0.92-0.97)每增加1 g / L; P <0.001)和恶性疟原虫无性寄生虫病在滑动阳性病例中(0.36(0.19-0.68)增加了10倍; P = 0.002)。基线间日间疟原虫细胞毒血症与Hackett 2级(12.66(1.31-122.56); P = 0.028),恶性疟原虫/间日体混合感染(0.16(0.03-1.00); P = 0.050),间日疟原虫无性寄生虫病( 5.68(0.98-33.04); P = 0.053)和血红蛋白(0.94(0.88-1.00); P = 0.056)。对于恶性疟原虫配子后血的治疗,独立的预测因素是AN vs AL治疗(4.09(1.43-11.65)),血红蛋白(0.95(0.93-0.97)),恶性疟原虫无性形式的存在与否(3.40(1.66-0.68) ))和治疗后天数(0.086(0.82-0.90))(P <0.001)。通过间日疟原虫无性形式的存在,可以预测治疗后间日间疟原虫的细胞凋亡(596(12-28,433); P <0.001)。与恶性疟原虫配子细胞成熟缓慢,血红蛋白低,无性寄生虫密度低和脾脏分级高,先前感染暴露/免疫性升高的标志物一致,是治疗前配子细胞阳性的重要因素。恶性疟原虫配子体细胞血症和血红蛋白之间持续的逆向联系表明随访过程中骨髓调节配子体细胞发生的重要作用。在间日疟原虫感染中,基线和治疗后配子细胞的运输与急性寄生虫负担呈正相关,反映了无性和性形式的发展之间的紧密联系。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号